Cell Reports (Nov 2023)

An obesogenic diet increases atherosclerosis through promoting microbiota dysbiosis-induced gut lymphocyte trafficking into the periphery

  • Ludivine Laurans,
  • Nirmala Mouttoulingam,
  • Mouna Chajadine,
  • Aonghus Lavelle,
  • Marc Diedisheim,
  • Emilie Bacquer,
  • Laura Creusot,
  • Nadine Suffee,
  • Bruno Esposito,
  • Nada Joe Melhem,
  • Wilfried Le Goff,
  • Yacine Haddad,
  • Jean-Louis Paul,
  • Dominique Rainteau,
  • Alain Tedgui,
  • Hafid Ait-Oufella,
  • Laurence Zitvogel,
  • Harry Sokol,
  • Soraya Taleb

Journal volume & issue
Vol. 42, no. 11
p. 113350

Abstract

Read online

Summary: Although high-fat diet (HFD)-induced gut microbiota dysbiosis is known to affect atherosclerosis, the underlying mechanisms remain to be fully explored. Here, we show that the progression of atherosclerosis depends on a gut microbiota shaped by an HFD but not a high-cholesterol (HC) diet and, more particularly, on low fiber (LF) intake. Mechanistically, gut lymphoid cells impacted by HFD- or LF-induced microbiota dysbiosis highly proliferate in mesenteric lymph nodes (MLNs) and migrate from MLNs to the periphery, which fuels T cell accumulation within atherosclerotic plaques. This is associated with the induction of mucosal addressin cell adhesion molecule 1 (MAdCAM-1) within plaques and the presence of enterotropic lymphocytes expressing β7 integrin. MLN resection or lymphocyte deficiency abrogates the pro-atherogenic effects of a microbiota shaped by LF. Our study shows a pathological link between a diet-shaped microbiota, gut immune cells, and atherosclerosis, suggesting that a diet-modulated microbiome might be a suitable therapeutic target to prevent atherosclerosis.

Keywords